We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prostate Cancer Prevention Trial With Quercetin and Genistein (QUERGEN)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2012 by Stephan C. Bischoff, MD, Professor, University of Hohenheim.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01538316
First Posted: February 24, 2012
Last Update Posted: May 15, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
University Hospital Tuebingen
Quercegen Pharmaceuticals
Information provided by (Responsible Party):
Stephan C. Bischoff, MD, Professor, University of Hohenheim
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2014
  Estimated Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)